Overall Status

Completed (2)

Recruiting (1)

Phase

phase 2 (2)

Sponsor

Aadi Bioscience, Inc. (1)

National Cancer Institute (NCI) (1)

University Hospital, Bordeaux (1)

Collaborator

Ministry for Health and Solidarity, France (1)

National Cancer Institute, France (1)

Intervention

abi-009 (1)

biopsy (1)

biospecimen collection (1)

ipilimumab (1)

nivolumab (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

procedure (1)

Funder Type

Industry (1)

NIH (1)

Other (1)

Study Type

Interventional (2)

Observational (1)

pecoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting

Acinar Cell Carcinoma
+93 more

Biospecimen Collection
+2 more

Birmingham, Alabama
+998 more

Aug 23, 2022

PEComa Trial in United States (ABI-009)

Completed

PEComa

ABI-009

Palo Alto, California
+8 more

Apr 29, 2022

Predictive of Efficacy Betablockers in PEComa and Vascular

Completed

PEComa
Hemangioma

Biopsy

Bordeaux, France

CHU de Bordeaux

Aug 19, 2016